Problem drinking and medication adherence among persons with HIV infection
Cite this article as: Cook, R.L., Sereika, S.M., Hunt, S.C. et al. J GEN INTERN MED (2001) 16: 83. doi:10.1111/j.1525-1497.2001.00122.x Abstract OBJECTIVE: To examine the relation between problem drinking and medication adherence among persons with HIV infection. DESIGN: Cross-sectional survey. SETTING/PARTICIPANTS: Two hundred twelve persons with HIV infection who visited 2 outpatient clinics between December 1997 and February 1998. MEASUREMENTS AND MAIN RESULTS: Nineteen percent of subjects reported problem drinking during the previous month, 14% missed at least 1 dose of medication within the previous 24 hours, and 30% did not take their medications as scheduled during the previous week. Problem drinkers were slightly more likely to report a missed dose (17% vs 12 %, P=.38) and significantly more likely to report taking medicines off schedule (45% vs 26%, P=.02). Among drinking subtypes, taking medications off schedule was significantly associated with both heavy drinking (high quantity/frequency) (adjusted odds ratio [OR], 4.70; 95% confidence interval [95% CI], 1.49 to 14.84; P<.05) and hazardous drinking (adjusted OR, 2.64; 95% CI, 1.07 to 6.53; P<.05). Problem drinkers were more likely to report missing medications because of forgetting (48% vs 35%, P=.10), running out of medications (15% vs 8%, P=.16), and consuming alcohol or drugs (26 % vs 3 %, P<.001). CONCLUSION: Problem drinking is associated with decreased medication adherence, particularly with taking medications off schedule during the previous week. Clinicians should assess for alcohol problems, link alcohol use severity to potential adherence problems, and monitor outcomes in both alcohol consumption and medication adherence. Key words adherence alcohol HIV infection
Presented in part at the 22
nd annual meeting of the Society of General Internal Medicine, San Francisco, Calif, May 1999. References
Report of the NIH Panel To Define Principles of Therapy of HIV Infection. Ann Intern Med. 1998;128:1057–78.
Vanhove GF, Schapiro JM, Winters MA, Merigan TC, Blaschke TF. Patient compliance and drug failure in protease inhibitor mono-therapy. JAMA. 1996;276:1955–6.
Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279:1977–83.
Mehta S, Moore RD, Graham NM. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11:1665–70.
Singh N, Squier C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8:261–9.
Samet JH, Libman H, Steger KA, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med. 1992;92:495–502.
Smith MY, Rapkin BD, Morrison A, Kammerman S. Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medications to self-termination of therapy. J Gen Intern Med. 1997;12:216–23.
Haubrich R, Little S, Dube M, et al. Self-reported treatment adherence and drug/alcohol use are associated with virologic outcomes in CCTG 570: a clinical strategy trial of HIV RNA antiretroviral (ARV) monitoring. Int Conf AIDS. 1998;12:597. Abstract.
Halkitis P, Remien R, Parsons JT, Stirratt MJ. Factors related to protease inhibitor (PI) adherence among sexually active men-who-have-sex-with-men. Int Conf AIDS. 1998;12:1034. Abstract.
Stone VE, Adelson-Mitty J, Duefield CA, Steger KA, Stein MD, Mayer KH. Adherence to protease inhibitor (PI) therapy in clinical practice: usefulness of demographics, attitudes and knowledge as predictors. Int Conf AIDS. 1998;12:588. Abstract.
Weidle PJ, Ganea CE, Ernst J, McGowan J, Irwin KL, Holberg SD. Multiple reasons for nonadherence to antiretroviral medications in an inner-city minority population: need for a multifaceted approach to improve adherence. Int Conf AIDS. 1998;12:593. Abstract.
Lefevre F, O’Leary B, Moran M, et al. Alcohol consumption among HIV-infected patients. J Gen Intern Med. 1995;10:458–60.
Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W Jr. Comorbidity and survival in HIV-infected men in the San Francisco Men’s Health Survey. Ann Epidemiol. 1996;6:420–30.
Rinaldi RC, Steindler EM, Wilford BB, Goodwin D. Clarification and standardization of substance abuse terminology. JAMA. 1988;259:555–7.
Isaacson JH, Butler R, Zacharek M, Tzelepis A. Screening with the Alcohol use Disorders Identification Test (AUDIT) in an inner-city population. J Gen Intern Med. 1994;9:550–3.
Sanchez-Craig M, Wilkinson DA, Davila R. Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkers. Am J Public Health. 1995;8:823–8.
Fleming MF, Barry KL, Manwell LB, Johnson K, London R. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA. 1997;277:1039–45.
Wechsler H, Davenport A, Dowdall G, Moeykens B, Castillo S. Health and behavioral consequences of binge drinking in college. A national survey of students at 140 campuses. JAMA. 1994;272:1672–7.
Babor TF, de la Fuente JR, Saunders J, Grant M. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. Geneva, Switzerland: World Health Organization; 1992.
Hecht FM, Colfax G, Swanson M, Chesney MA. Adherence and effectiveness of protease inhibitors in clinical practice. Fifth Annual Conference of Retroviral and Opportunistic Infections. 1998;107:1–5.
Condor B. The psychology of compliance. Posit Aware. 1997;8:18–20.
Ferrando SJ, Wall TL, Batki SL, Sonensen JL. Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease. Am J Drug Alcohol Abuse. 1996;22:475–87.
Friedland G. HIV disease in substance abusers: treatment issues. In: Sande MA, Volberding PA, eds. The Medical Management of AIDS. 6th ed. Philadelphia: WB Saunders; 1999:575–91.
Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383–6.
Melnikow J, Kiefe C. Patient compliance and medical research: issues in methodology. J Gen Intern Med. 1994;9:96–105.
Conigliaro J, Lofgren RP, Hanusa BH. Screening for problem drinking: impact on physician behavior and patient drinking habits. J Gen Intern Med. 1998;13:251–6.
Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Reader. 1999;9:329–38.
Amsten JH, Grant RW, Domas PA, et al. Adherence with antiretroviral therapy in HIV-infected drug users: how does self-report compare with electronic monitors? J Gen Intern Med. 2000;15(suppl 1):51–2.
Hecht FM. Measuring HIV treatment adherence in clinical practice. AIDS Clin Care. 1998;10:57–9.
Miller LG, Hays RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Reader 2000;10:177–85.
Potter L, Oakley D, de Leon-Wong E, Canamar R. Measuring compliance among oral contraceptive users. Fam Plann Perspect. 1996;28:154–8.
Sontag D, Richardson L. Doctors withhold H.I.V. pill regimen from some. New York Times. March 2, 1997;1,35.
Lerner BH, Gulick RM, Dubler NN. Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Ann Intern Med. 1998;129:573–8.
Bryant KJ, Levine GL. Drinking and HIV: knowledge and context. Focus. 1999;14:1–8.
PubMed Copyright information
© Blackwell Science Inc 2001